Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy.
作者信息
Smith J A, Kalimullah F A, Erickson C P, Peng L S
机构信息
Oregon Health and Science University.
出版信息
Dermatol Online J. 2015 Sep 17;21(9):13030/qt1vt8c3vt.
PMID:26437283
Abstract
Scleromyxedema (SM) is a chronic and progressive fibromucinous disease with no known etiology. We report a patient with scleromyxedema associated with hepatitis C virus, successfully treated with interferon and ribavirin therapy.
摘要
Zotero 插件